Heart DiseasesNCT05174442
ACCESS Registry: A Post Market Follow-up Study to Monitor the Safety, Performance and Usability of Occlutech Accessory Medical Devices
An observational study of Heart Diseases, run by Occlutech International AB at 36 sites in 2 countries.
Trial summary
The registry is an international, multicenter, non-randomized, non-invasive study to assess the safety, performance and usability of the Occlutech Accessories "Occlutech Delivery Set (ODS), Occlutech Pistol Pusher (OPP), Occlutech Occlusions-Pusher (OOP) and Occlutech Sizing Balloon (OSB)" used for implantation… Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Heart Diseases
- How many people
- 685 participants
- Where
- 36 sitesin 2 countries
- Study dates
- 14 Oct 2021to 1 Jan 2027
- How long will I take part?
- 6 Months
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: All subjects who underwent implantation procedure with an Occlutech accessory medical device and cardiac implants can be included. Preconditions depend exclusively on the requirements outlined in the applicable Instruction for Use of the implant and the accessories.
Who may be able to join
- Inclusion Criteria depend exclusively on the requirements outlined in the applicable Instruction for Use for accessory medical devices and cardiac implant devices.
- All subjects who underwent implantation procedure with an Occlutech accessory medical device and cardiac implants can be included
Who cannot join
- Exclusion Criteria depend exclusively on the requirements outlined in the applicable Instruction for Use and if applicable in the corresponding protocol of the investigation on the Occlutech implant devices.
Trial locations and contacts
36 sites in 2 countries. Contact the study team or a site near you to ask about taking part.
36 sites in 2 countries
Turkey (Türkiye)33 sites, 32 recruiting
- Recruiting
Çukurova Üniversitesi Tıp Fakültesi Balcalı Hastanesi
Adana, Balcalı, 01330
Fadli Demir, MD, fadlidemir@yahoo.com
Fadli Demir
- Recruiting
Adana City Training and Research Hospital
Adana
İbrahim Halil Kurt, Prof. Dr., MD, ibrahimhalilkurt@gmail.com
İbrahim Halil Kurt, Prof. Dr., MD
- Not yet recruiting
Medicana International Ankara Hastanesi
Ankara, Söğütözü, 06520
Engin Bozkurt, Prof.
- Recruiting
Ankara Etlik Şehir Hastanesi
Ankara, Yenimahalle, 06170
I. Hakan Güllü, MD, 0532 052 14 26, drgullu@gmail.com
I. Hakan Güllü, MD
- Recruiting
Hacettepe Üniversitesi Hastanesi
Ankara, 06230
Ergün Barış Kaya, Prof.
- Recruiting
Gazi University Medical Faculty Hospital Adult
Ankara
Salih Topal, MD
- Recruiting
Gazi University Medical Faculty Hospital Pediatric
Ankara
Serdar Kula, MD, +90 555 368 49 26, kula@gazi.edu.tr
Yaren Tercanlı, SC, +90 537 470 45 94, yaren.tercanli@medex-smo.com
- Withdrawn
Antalya Akdeniz Üniversitesi Hastanesi
Antalya, Konyaaltı, 07070
- Recruiting
Antalya Training and Research Hospital (Adult)
Antalya
Şakir Arslan, Prof.
- Recruiting
Antalya Training and Research Hospital (Pediatric)
Antalya
Abdullah Kocabaş, Prof.
- Recruiting
Aydın Adnan Menderes Üniversitesi Hastanesi
Aydin, Efeler, 09100
Serkan Fazlı Çelik, 5067795119, docser2003@yahoo.com
Serkan Fazlı Çelik
- Not yet recruiting
SBÜ Bursa Yüksek İhtisas Eğitim ve Araştırma Hastanesi
Bursa, 16310
Hasan Arı, Prof.
- Recruiting
Pamukkale Üniversitesi Klinik Uygulama ve Araştırma Merkezi Hastanesi
Denizli, 20160
Doğu Akif Kılıç, Prof.
- Recruiting
Dicle Üniversitesi Tıp Fakültesi Hastanesi
Diyarbakır, Sur, 21280
Alper Akın, 05436228088, alperakin1@hotmail.com
Alper Akın
- Not yet recruiting
Dicle Üniversitesi Tıp Fakültesi Sağlık ve Araştırma Hastanesi
Diyarbakır, 21100
Mehmet Ata Akil, Prof.
- Recruiting
Eskişehir Osmangazi University Adult
Eskişehir
Yüksel Çavuşoğlu, MD
- Recruiting
Eskişehir Osmangazi University Pediatric
Eskişehir
Birsen Uçar, MD
- Recruiting
Gaziantep Üniversitesi Şahinbey Araştırma ve Uygulama Hastanesi
Gaziantep, Şehitkamil, 27310
Osman Başpınar, Prof. Dr, 5323455477, osmanbaspinar@hotmail.com
Osman Başpınar
- Recruiting
Isparta Süleyman Demirel Üniversitesi Araştırma ve Uygulama Hastanesi
Isparta, 32260
Fathi Akif Aksoy, Prof.
- Recruiting
Bezmialem Tıp Fakültesi Hastanesi
Istanbul, Fatih, 34093
Ramazan Ozdemır, Prof. Dr., 05324636064, rozdemir@bezmialem.edu.tr
Ramazan Ozdemır, Prof. Dr.
- Recruiting
İstanbul Mehmet Akif Ersoy Göğüs Kalp ve Damar Cerrahisi Eğitim ve Araştırma Hastanesi
Istanbul, Küçükçekmece, 34303
Mehmet Ertürk, Prof.
- Recruiting
İstanbul Mehmet Akif Ersoy Göğüs Kalp ve Damar Cerrahisi Eğitim ve Araştırma Hastanesi
Istanbul, Küçükçekmece, 34303
Alper Güzeltaş, Prof.
- Not yet recruiting
Istanbul Basaksahir Cam and Sakura City Hospital(Adult)
Istanbul
Alev Kılıçgedik, Prof. Dr., MD, akilicgedik@yahoo.com
Alev Kılıçgedik, Prof. Dr., MD
- Recruiting
Istanbul Basaksehir Cam and Sakura City Hospital (Pediatric)
Istanbul
İbrahim Cansaran Tanıdır, Assoc. Prof. Dr., MD
- Not yet recruiting
Istanbul Prof. Dr. Suleyman Yalcin City Hospital
Istanbul
Mustafa Çalışkan, MD, Prof. Dr., caliskandr@gmail.com
Mustafa Çalışkan, MD, Prof. Dr.
- Recruiting
İzmir Şehir Hastanesi
Izmir, Bayraklı, 35540
Barış Kılıçaslan, MD, 0505 588 81 88, kiliaslanbaris@yahoo.com
Barış Kılıçaslan, MD
- Recruiting
Karaman Eğitim ve Araştırma Hastanesi
Karaman, Merkez, 70200
Ahmet Yılmaz, Dr.Öğr., 0090 532 632 91 15, Dr.ahmetyilmaz@gmail.com
Ahmet Yılmaz
- Recruiting
Kocaeli University Hospital
Kocaeli
Teoman Kılıç, Prof.
- Recruiting
Necmettin Erbakan Üniversitesi Meram Tıp Fakültesi
Konya, 142080
Mehmet Akif Düzenli, Prof.
- Recruiting
İnönü Üniversitesi Tıp Fakültesi Hastanesi
Malatya, Battalgazi, 44280
05324666432
Özlem Elkiran, Prof.
- Recruiting
Mardin Artuklu Üniversitesi Tıp Fakültesi Hastanesi
Mardin, 47200
Mehmet Zülkif Karahan, Prof.
- Not yet recruiting
Mersin University Faculty of Medicine Hospital
Mersin
Derya Karpuz, Assoc. Prof. Dr, MD, drderyakarpuz@gmail.com
Derya Karpuz, Assoc. Prof. Dr., MD
- Recruiting
S.B.Ü Ahi Evren Göğüs Kalp ve Damar Cerrahisi Eğitim ve Araştırma Hastanesi
Trabzon, 61040
Ali Rıza Akyüz, Prof.
Germany3 sites, 2 recruiting
- Recruiting
Universitätsklinikum Erlangen
Erlangen, 91054
Mohamed Marwan, MD, 0049 0160-49 17 39, mohamed.morwan@uk-erlangen.de
Yvonne Burkhardt, SC, 0049 0160-49 17 39, yvonne.burkhardt@uk-erlangen.de
- Active, not recruiting
Kliniken Maria Hilf GmbH
Mönchengladbach
- Recruiting
Klinikum der Universität München
München, 81377
Nikolaus Haas, Prof. Dr. med.
About this study
Official title: A Registry-based, Multicenter, International, Post Market Follow-up Study to Monitor the Safety, Performance and Usability of Occlutech Accessory Medical Devices:Occlutech Delivery Set (ODS), Occlutech Pistol Pusher (OPP), Occlutech Occlusions-Pusher (OOP), Occlutech Sizing Balloon (OSB) Used During to Implantation Procedures of Cardiac Implant Devices
The registry is an international, multicenter, non-randomized, non-invasive study to assess the safety, performance and usability of the Occlutech Accessories "Occlutech Delivery Set (ODS), Occlutech Pistol Pusher (OPP), Occlutech Occlusions-Pusher (OOP) and Occlutech Sizing Balloon (OSB)" used for implantation procedures (catheter-based interventions) of cardiac implants via completing surveys (questionnaires) for the accessory medical devices by the investigators.
Read the detailed description
The registry is an international, multicenter, non-randomized, non-invasive study to assess the safety, performance and usability of the Occlutech Accessories "Occlutech Delivery Set (ODS), Occlutech Pistol Pusher (OPP), Occlutech Occlusions-Pusher (OOP) and Occlutech Sizing Balloon (OSB)" used for implantation procedures (catheter-based interventions) of cardiac implants via completing surveys (questionnaires) for the accessory medical devices by the investigators.
A survey (questionnaire) of each accessory medical device should be completed by investigator in order to assess safety of the accessory by success of implantation procedure, occurrence of adverse events during implantation procedure or as late term effects resulting from implantation procedure, user harm related to the accessory, procedure, reported device deficiencies related to the accessory. The Surveys (questionnaires) also include questions related to performance, usability and compatibility with devices and other accessories. Subjects should be treated according to instructions-for-use of the implants and accessories and according to clinical routine. The devices must have been used exclusively by physicians who are experienced in cardiac catheterization techniques and who are experienced in using the products in the process of interventional operations.
- Conditions
- Heart Diseases
- Medical subject headings
- Heart Diseases
What is being measured
The primary outcome is the main question the study is designed to answer.
Occurence of safety events
The primary safety endpoint is defined as the rate of incidences of (peri-) procedural adverse events / rate of (serious) adverse device effects ((S)ADEs) during implantation or as late effects of implantation procedure. A serious adverse device effect (SADE) is defined as an event that is clearly caused by the device such as:
- device dislocation (during the procedures with OPP, OOP,ODS)
- embolization related with procedure and accessories
- Late effect of implantation procedure: damage to the vessels and heart caused by the accessories
- any circumstances that require device removal related with procedure or accessories used during the implantation
- Signs of thrombosis
Measured: 6 months
Secondary outcomes (1)
Performance, usability:
will be assessed in terms of mechanical performance, procedural data by completing the survey (questionnaire) for each accessory with grading. Compatibility of ODS, OPP, OOP with cardiac implant devices or/and other accessory medical devices.
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Dec 2021
- Study start14 Oct 2021
- Primary completion1 Jan 2027 (estimated)
- Study completion1 Jan 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Heart DiseasesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Other
- Enrolment
- 685 participants (estimated)
- Target duration
- 6 Months
Sponsor and investigators
- Lead sponsor
- Occlutech International AB
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05174442
- Sponsor's protocol ID
- Occ2021_03
- Status last verified
- Jul 2025
- First submitted
- 13 Dec 2021
- Last updated
- 4 Dec 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 4 Dec 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Registry-based, Multicenter, International, Post Market Follow-up Study to Monitor the Safety, Performance and Usability of Occlutech Accessory Medical Devices:Occlutech Delivery Set (ODS), Occlutech Pistol Pusher (OPP), Occlutech Occlusions-Pusher (OOP), Occlutech Sizing Balloon (OSB) Used During to Implantation Procedures of Cardiac Implant Devices
- ClinicalTrials.gov ID
- NCT05174442
- Acronym / sponsor ID
- Occ2021_03
- Conditions
- Heart Diseases
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 685 participants (estimated)
- Lead sponsor
- Occlutech International ABIndustry (pharma, biotech, devices)
- Study start
- 14 Oct 2021 (actual)
- Primary completion
- 1 Jan 2027 (estimated)
- Study completion
- 1 Jan 2027 (estimated)
- First posted
- 30 Dec 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The registry is an international, multicenter, non-randomized, non-invasive study to assess the safety, performance and usability of the Occlutech Accessories "Occlutech Delivery Set (ODS), Occlutech Pistol Pusher (OPP), Occlutech Occlusions-Pusher (OOP) and Occlutech Sizing Balloon (OSB)" used for implantation procedures (catheter-based interventions) of cardiac implants via completing surveys (questionnaires) for the accessory medical devices by the investigators.
Detailed description
The registry is an international, multicenter, non-randomized, non-invasive study to assess the safety, performance and usability of the Occlutech Accessories "Occlutech Delivery Set (ODS), Occlutech Pistol Pusher (OPP), Occlutech Occlusions-Pusher (OOP) and Occlutech Sizing Balloon (OSB)" used for implantation procedures (catheter-based interventions) of cardiac implants via completing surveys (questionnaires) for the accessory medical devices by the investigators.
A survey (questionnaire) of each accessory medical device should be completed by investigator in order to assess safety of the accessory by success of implantation procedure, occurrence of adverse events during implantation procedure or as late term effects resulting from implantation procedure, user harm related to the accessory, procedure, reported device deficiencies related to the accessory. The Surveys (questionnaires) also include questions related to performance, usability and compatibility with devices and other accessories. Subjects should be treated according to instructions-for-use of the implants and accessories and according to clinical routine. The devices must have been used exclusively by physicians who are experienced in cardiac catheterization techniques and who are experienced in using the products in the process of interventional operations.
Study design
- Observational model
- Other
- Time perspective
- Other
- Target follow-up
- 6 Months
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- All subjects who underwent implantation procedure with an Occlutech accessory medical device and cardiac implants can be included. Preconditions depend exclusively on the requirements outlined in the applicable Instruction for Use of the implant and the accessories.
Key inclusion criteria (2 listed)
- Inclusion Criteria depend exclusively on the requirements outlined in the applicable Instruction for Use for accessory medical devices and cardiac implant devices.
- All subjects who underwent implantation procedure with an Occlutech accessory medical device and cardiac implants can be included
Key exclusion criteria (1 listed)
- Exclusion Criteria depend exclusively on the requirements outlined in the applicable Instruction for Use and if applicable in the corresponding protocol of the investigation on the Occlutech implant devices.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Occurence of safety events
Time frame: 6 months
The primary safety endpoint is defined as the rate of incidences of (peri-) procedural adverse events / rate of (serious) adverse device effects ((S)ADEs) during implantation or as late effects of implantation procedure. A serious adverse device effect (SADE) is defined as an event that is clearly caused by the device such as: * device dislocation (during the procedures with OPP, OOP,ODS) * embolization related with procedure and accessories * Late effect of implantation procedure: damage to the vessels and heart caused by the accessories * any circumstances that require device removal related with procedure or accessories used during the implantation * Signs of thrombosis
1 secondary outcome
Performance, usability:
Time frame: 6 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Dec 2025.
Related trials for Heart Diseases
Not yet recruiting
Effect of Stress Ball Use During Femoral Arterial Sheath Removal After Coronary Angiography
Femoral Arterial Sheath Removal, Stress Ball
Active, not recruiting
Shockwave™ vs Surgical Endarterectomy for Calcified Severe Common Femoral Artery Stenosis: Comparison of Efficacy, Safety and Long-Term Outcomes
Common Femoral Artery Stenosis, Calcification; Heart
RecruitingObservational study
AI-powered ECG Analysis Using Willem™ Software in High-risk Cardiac Patients (WILLEM)
Cardiomyopathies, Cardiac Arrest
RecruitingPhase 4
The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life(COREVIVE-HFrEF)
Heart Failure With Reduced Ejection Fraction, Iron Deficiency
Recruiting
Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR
Aortic Stenosis Treated With TAVI, Aortic Diseases
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
36 sites in 2 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Heart Diseases, run by Occlutech International AB at 36 sites in 2 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 4 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 36 sites in Turkey (Türkiye), Germany. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Gönül Sönmez Utkun (+90 542 826 11 95, gonul.sonmezutkun@occlutech.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Occurence of safety events (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Dec 2025.